Machine learning in virtual screening.

Area of Science:

• Computational chemistry
• Cheminformatics
• Drug discovery

Background:

• Virtual screening is crucial for identifying novel drug candidates.
• Machine learning (ML) offers powerful tools to enhance virtual screening efficiency.
• Supervised learning techniques are increasingly applied to prioritize molecules.

Purpose of the Study:

• To review recent applications of machine learning in virtual screening.
• To focus on supervised learning methods for prioritizing molecules against protein targets.
• To discuss data preparation, validation, optimization, and search methodologies.

Main Methods:

• Utilizing supervised machine learning algorithms (e.g., naïve Bayesian classifiers, support vector machines, neural networks, decision trees).
• Applying ML to both ligand-based similarity searching and structure-based docking.
• Reviewing traditional regression techniques in the context of virtual screening.

Main Results:

• Machine learning significantly improves the prioritization of molecular databases for drug discovery.
• Both ligand-based and structure-based virtual screening methods benefit from ML integration.
• Effective ML application requires careful consideration of data preparation and validation.

Conclusions:

• Machine learning is a transformative technology in modern virtual screening.
• Supervised learning algorithms enhance the accuracy and efficiency of identifying potential drug candidates.
• Further advancements in ML methodologies will continue to impact drug discovery pipelines.